China SXT Pharmaceuticals SXTC
NASDAQ SXTC
$2.96 -0.05 (-1.66%)
At close: Oct 1, 2026 · 4:00 PM EDT

China SXT Pharmaceuticals (SXTC) Change in Cash (2017 - 2019)

Updated

China SXT Pharmaceuticals' Change in Cash was $10.05 million in FY2026 (year ended Mar 31, 2026), up 66.0% from $6.05 million in FY2025.

Analysis

China SXT Pharmaceuticals (SXTC) Change in Cash (2017 - 2019) Analysis & Trends

From FY2017 onward, China SXT Pharmaceuticals has reported Change in Cash for 10 fiscal years.

  • Change in Cash shows a five-year compound annual growth rate of 10.6% (FY2021 to FY2026).
  • The FY2026 figure marks the highest annual Change in Cash in data going back to FY2017.
  • Per Business Quant data, Change in Cash in earlier fiscal years was $6.05 million in FY2025, -$5.29 million in FY2024, $1.8 million in FY2023 (-18.6%) and $2.21 million in FY2022 (-63.6%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -1.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -2.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.49 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 739.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.64 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -4.45 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -727.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 649.20 Mn
10 China SXT Pharmaceuticals 39,500.23 -85.91 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 8.24 Mn
Dec 31, 2018 592,197.00
Dec 31, 2017 54,131.00
API Access

China SXT Pharmaceuticals Change in Cash API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-cash&ticker=SXTC&period=max&api_key=YOUR_API_KEY